BRD8 Antikörper (AA 25-75)
-
- Target Alle BRD8 Antikörper anzeigen
- BRD8 (Bromodomain Containing 8 (BRD8))
-
Bindungsspezifität
- AA 25-75
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRD8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-BRD8 Antibody, Affinity Purified
- Homologie
- Mouse
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 25 and 75 in Uniprot entry Q9H0E9.2)
- Isotyp
- IgG
- Top Product
- Discover our top product BRD8 Primärantikörper
-
-
- Applikationshinweise
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- BRD8 (Bromodomain Containing 8 (BRD8))
- Andere Bezeichnung
- BRD8 (BRD8 Produkte)
- Synonyme
- SMAP antikoerper, SMAP2 antikoerper, p120 antikoerper, 2610007E11Rik antikoerper, 4432404P07Rik antikoerper, bromodomain containing 8 antikoerper, BRD8 antikoerper, Brd8 antikoerper
- Hintergrund
- Background: BRD8 (bromodomain-containing 8) has been identified as a thyroid hormone receptor coactivator as well as a GTPase activating protein (GAP) for Arf6 that regulates clathrin-dependent vesicle trafficking. BRD8 has also been identified as a gene upregulated during formation of the neointima layer of blood vessels and named smooth muscle activating protein 2 (SMAP2).
- Gen-ID
- 10902
- NCBI Accession
- NP_631938
- UniProt
- Q9H0E9
-